Influence of aromatase inhibitors on insulin sensitivity, liver and heart function in obese men.

Trial Profile

Influence of aromatase inhibitors on insulin sensitivity, liver and heart function in obese men.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Aug 2015

At a glance

  • Drugs Letrozole (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics
  • Acronyms HEPAROB
  • Most Recent Events

    • 15 Aug 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 02 Jun 2015 Planned End Date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov
    • 02 Jun 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top